期刊文献+

加用大剂量地塞米松短程治疗重度甲亢性心力衰竭临床观察 被引量:2

原文传递
导出
摘要 目的观察大剂量地塞米松短程疗法治疗甲亢性心力衰竭的疗效。方法将明确诊断为甲亢性心力衰竭的患者随机分为治疗组和对照组,治疗组增加地塞米松15mg静脉滴注,1次/天,用7天,1周后观察两组疗效变化,对照组治疗无效的患者再增加地塞米松治疗1周,比较其疗效。结果治疗组疗效明显优于对照组,对照治疗组加用地塞米松后疗效显著,未发现明显不良反应。结论加用大剂量地塞米松短程治疗重度甲亢性心力衰竭疗效显著。
出处 《临床内科杂志》 CAS 2009年第8期556-557,共2页 Journal of Clinical Internal Medicine
  • 相关文献

参考文献5

二级参考文献28

  • 1李梅,邱明才,李欣,周征,韩俊领,赵英新.Graves病合并白细胞减少患者血清对骨髓细胞粒-单核细胞系集落形成单位生长的影响[J].中华医学杂志,2002,82(9):643-645. 被引量:21
  • 2张洁,王邦茂,吕宗舜,刘文天,邱明才.Graves病甲亢患者慢性胃炎发病的免疫学机制[J].天津医药,2007,35(5):326-328. 被引量:8
  • 3Cappola AR, Fried LP, Arnold AM. Thyroid status, cardiovascular risk, and mortality in older adults[J]. JAMA, 2006,295(9) :1033-1041.
  • 4Fazio S, Palmieri EA, Lombardi G, et al. Effects of thyroid hormone on the cardiovascular system[J]. Recent Prog Horm Res,2004,59:31-50.
  • 5Carr AN,Kranlas EG. Thyroid hormone regulation of calcium cycling proteins[J]. Thyroid,2002,12(6) :453-457.
  • 6Wang B,Ouyang J. Effects of triiodo-thyronine on angiotensin- induced cardiomyocyte hypertrophy: reversal of increased beta-myosin heavy chain gene expression [ J ]. Can J Physiol Pharmacol, 2006,84 (8-9) : 935-941.
  • 7Colzani RM, Emdin M, Conforti C, et al. Hyperthyroidism is associated with lengthening of ventricular repolarization[J]. Cli Endocrinol, 2001,55 ( 1 ) : 27-32.
  • 8Carvalho-Bianco SD,Kim BW,Zhang JX,et al. Chronic cardiacspecific thyrotoxicosis increases yocardial beta-adrenergic responsiveness[J]. Mol Endocrinol,2004,18(7) :1840-1849.
  • 9Bachman ES, Hampton TG, Dhillon H, et al. The metabolic and cardiovascular effects of hyperthyroidism are largely independent of beta-adrenergie stimulation[J]. Endocrinology, 2004,145(6):767-2774.
  • 10Vargas F, Moreno JM, Rodriguez-GomezI et al. Vascular and renal function in experimental thyroid disorders[J]. European J Endoerinol, 2005,154, (2):197-212.

共引文献105

同被引文献31

  • 1张敬鸣,梅翼萍,林伟,陈树.地塞米松球周注射治疗Graves眼病临床观察[J].实用医院临床杂志,2005,2(1):44-45. 被引量:8
  • 2孙芳,陈美云.急性肺损伤/急性呼吸窘迫综合征药物治疗进展[J].国际呼吸杂志,2006,26(11):813-816. 被引量:7
  • 3Grbovic L,Radenkovic M.Thcrapeutic use of glucocorticoids and immunosuppressive agents[J],Srp Arh Celok Lek,2005;133(Suppl 1):67-73.
  • 4Patrizio Caturegli,Hiroaki Kimura,Roberto Rocchi,et al.Autoimmune thyroid diseases[J].Curr Opin Rheumatol,2007;19:44-48.
  • 5Pallardy M.Induclion of apoptosis in lymphocytes by glucocorticoids:between physiology and pharmacology[J].C R Seances Soc Biol Fil, 1998; 192:1051 - 1063.
  • 6Beato M,Herrlich P, Schutz G.Steroid hormone receptors:many actors in search ofa plot[J].Cell,1995;83:851-857.
  • 7Sonia L,Planey.Glucocorticoid-lnduced Apoptosis in Lymphocytes[J]. Biochemical and Biophysical Research Communications,2000;279(2):307-312.
  • 8Zhang Z,Jones S,Hagod JS,et al.STAT3 acts as a coactivator of glucocorticoid receptor singaling[J].J Biol Chem, 1997;272:30607-30610.
  • 9Auphan N,Didonata JA,Rosette C,et al.Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis[J]. Science, 1995;270:286-290.
  • 10Almawi WY, Beyhum HN,Rahme AA,et al.Regulation of cytokine and cytokine receptor expression by gtucocorticoids[J].J Leukoc Biol, 1996;60:563-572.

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部